FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Panel to Review Antibiotic NDA Next Month

[ Price : $8.95]

FDA tells Arpida Ltd. that the agency's Anti-Infective Drugs Advisory Committee will review next month its NDA for intravenous icl...

FDA Approves St. Judes Angio-Seal Evolution Device

[ Price : $8.95]

FDA approves St. Jude Medicals Angio-Seal Evolution Vascular Closure Device, intended for use in sealing femoral artery punctures ...

Dingell, Stupak Question FDA Consumer Ad Web Site

[ Price : $8.95]

Reps. Dingell and Stupak question FDAs use of a drug industry PR firm to create a consumer Web site on DTC ads and challenge Bayer...

FDA Clears Surgical Sponge Detecting Wand

[ Price : $8.95]

FDA clears an RF Surgical Systems 510(k) for the Blair-Port Wand as a reusable scanning device intended for use with the companys ...

FDA Clears U.S. Spine System

[ Price : $8.95]

FDA clears a U.S. Spine 510(k) for the Preference 2 Complex Spine System, intended for use in treating complex spinal disorders.

FDA Regulation Examined in Law Review

[ Price : $8.95]

Cornell Law Review authors raise questions about a number of FDA regulatory issues.

Comments Reopened on DrugsAbuse Potential

[ Price : $8.95]

Federal Register Notice: FDA reopens the comment period on 10 drug substances and their abuse potential, actual abuse, medical use...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites A1 Discount Vitamins, Boehringer-Ingelheim, Richard Holub, Laboratory Corp. of A...

Drug Safety Needs Same Emphasis as Efficacy: FDA

[ Price : $8.95]

CDER biostatistics director Robert O'Neill ays drug safety should be accorded the same level of attention as efficacy in drug deve...